400 related articles for article (PubMed ID: 34913366)
1. Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes.
Ohman RE; Yang EH; Abel ML
J Am Heart Assoc; 2021 Dec; 10(24):e023852. PubMed ID: 34913366
[TBL] [Abstract][Full Text] [Related]
2. Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations.
Patel SR; Suero-Abreu GA; Ai A; Ramachandran MK; Meza K; Florez N
Front Oncol; 2023; 13():1124447. PubMed ID: 37361603
[TBL] [Abstract][Full Text] [Related]
3. Cardio-Oncology Health Disparities: Social Determinants of Health and Care for Black Breast Cancer Survivors.
Cousin L; Roper N; Nolan TS
Clin J Oncol Nurs; 2021 Oct; 25(5):36-41. PubMed ID: 34533529
[TBL] [Abstract][Full Text] [Related]
4. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Parent S; Pituskin E; Paterson DI
Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
[TBL] [Abstract][Full Text] [Related]
5. Disparities in Cardiovascular Disease-Related Outcomes Among Cancer Survivors in the United States: A Systematic Review of the Literature.
Bikomeye JC; Awoyinka I; Kwarteng JL; Beyer AM; Rine S; Beyer KMM
Heart Lung Circ; 2024 May; 33(5):576-604. PubMed ID: 38184426
[TBL] [Abstract][Full Text] [Related]
6. Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association.
Addison D; Branch M; Baik AH; Fradley MG; Okwuosa T; Reding KW; Simpson KE; Suero-Abreu GA; Yang EH; Yancy CW;
Circulation; 2023 Jul; 148(3):297-308. PubMed ID: 37377045
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement.
Ahmad J; Muthyala A; Kumar A; Dani SS; Ganatra S
Curr Cardiol Rep; 2022 Sep; 24(9):1117-1127. PubMed ID: 35759170
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients.
Balaji S; Antony AK; Tonchev H; Scichilone G; Morsy M; Deen H; Mirza I; Ali MM; Mahmoud AM
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626782
[TBL] [Abstract][Full Text] [Related]
9. Cardio-oncology: need for novel structures.
Michel L; Rassaf T
Eur J Med Res; 2019 Jan; 24(1):1. PubMed ID: 30606260
[TBL] [Abstract][Full Text] [Related]
10. Disparities in cardio-oncology: Implication of angiogenesis, inflammation, and chemotherapy.
Vera CD; López AR; Ewaneewane AS; Lewis K; Parmisano S; Mondejar-Parreño G; Upadhyaya C; Mullen M
Life Sci; 2023 Nov; 332():122106. PubMed ID: 37730108
[TBL] [Abstract][Full Text] [Related]
11. [Heart and cancer: cardio-oncology].
Michel L; Rassaf T
Herz; 2024 Mar; 49(2):111-117. PubMed ID: 38289420
[TBL] [Abstract][Full Text] [Related]
12. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
[TBL] [Abstract][Full Text] [Related]
13. Tailored to a Woman's Heart: Gender Cardio-Oncology Across the Lifespan.
Chen MH; Epstein SF
Curr Cardiol Rep; 2023 Nov; 25(11):1461-1474. PubMed ID: 37819431
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Prevent Cardiotoxicity.
Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
[TBL] [Abstract][Full Text] [Related]
15. Management of Cardiovascular Disease in Women With Breast Cancer.
Barish R; Lynce F; Unger K; Barac A
Circulation; 2019 Feb; 139(8):1110-1120. PubMed ID: 30779651
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
17. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
Khouri MG; Klein MR; Velazquez EJ; Jones LW
Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
[TBL] [Abstract][Full Text] [Related]
19. How to Develop a Cardio-Oncology Clinic.
Snipelisky D; Park JY; Lerman A; Mulvagh S; Lin G; Pereira N; Rodriguez-Porcel M; Villarraga HR; Herrmann J
Heart Fail Clin; 2017 Apr; 13(2):347-359. PubMed ID: 28279420
[TBL] [Abstract][Full Text] [Related]
20. From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity.
Ederhy S; Devos P; Cohen A; Pinna B; Bretagne M; Nguyen LS; Salem JE
Therapie; 2022; 77(2):197-206. PubMed ID: 34895759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
